| Term 
 | Definition 
 
        | 5-HETE lipoxygenase pathway product inhibit platelet aggregation serve as chemotactic factor to attract leukocyte to site of injury |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 5-HPETE lipoxygenase pathway product no physiological function |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acarbose alpha-glucosidase inhibitor fungal metabolite derived from actinomyces |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acetaminophen p-aminophenol useful for pain and fever NOT inflammation do not inhibit COX overdose can lead to hepatic necrosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acetanilide p-aminophenol useful for pain and fever NOT inflammation do not inhibit COX overdose can lead to hepatic necrosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acetohexamide 1st Gen Sulfonylurea   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alprostadil PGE1 analog Maintain patency of ductus arteriosis after birth Erectile dysfunction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Amylin 37 amino acid peptide hormone secreted by pancreatic beta cells at same time as insulin Contributes to glycemic control Slow gastric emptying Inhibition of digestive secretion Inhibiting secretion of glucagon |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anthranilic Acid NSAID Reversible competitive inhibitor of COX Analog of salicylic acid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Arachidonic Acid Fatty Acid Precursor to Eicosanoids Released from cell membrane via PLA2 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Insulin Aspart Rapid Acting Insulin Eliminates ability to dimerize/hexamerize and results in faster absorption rate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aspirin  Type 2 salicylate ester Analgesic, antipyretic, anti-inflammatory Irreversible COX inhibitor. After acetylation of COX, salicylic acid acts as a reversible inhibitor. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aspirin Salt NSAID Type 2 salicylic acid ester Irreversible COX inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bimatoprost Synthetic PGF agent Used as eye drops for ocular hypertension and glaucoma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Canagiflozen SGLT-2 Inhibitor   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Carboprost PGF analog Used in combination with mifepristone as abortifacient Used to stimulate uterine contractions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Carprofen NSAID Propionic Acidveterinary analgesic
 both rings are COPLANAR--does not bind site 3  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Celecoxib NSAID COX 2 inhibitor Inhibit production of PGI2, may increase risk of vascular disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Chlorpropamide Sulfonylurea Extremely long half life/duration of action Potentially prolong hypoglycemia Potentially potentiate ADH sensitivity (H2O retention) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Choline Salicylate NSAID Type 1 salicylic acid ester   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dapagliflozin SGLT-2 Inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Detemir Insulin Long acting insulin Forms hexamer, slowly resleasing Monomer is more lipophilic--bound to albumin in circulation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Diclofenac NSAID Anthranilic Acid Analog Inhibits COX and lipoxygenase Inhibits release and reuptake of arachidonic acid optimal spacing of atoms between site 1 & 2 increases potency   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dinoprostone PGE2 analog Used in combination with mifepristone as abortifacient Stimulates uterine contraction Used as a vaginal suppository for induction of labor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Empagliflozin SGLT-2 Inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fenoprofen NSAID Propionic Acid Derivative Inhibits COX & lipoxygenase   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Flubiprofen NSAID Propionic Acid Derivative Opthalmic and oral systemic use |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Glargine Insulin Long acting insulin Isoelectric point neutral at physiological pH Microcrystal precipitate forms--slowly releases insulin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Glimepiride 3rd Generation Sulfonylurea Stimulate insulin secretion Stimulate translocation of GLUT4 from cytoplasm to cell membrane |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Glipizide 2nd Gen Sulfonylurea   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Glulisine Insulin Rapid Acting Insulin Eliminates ability to dimerize/hexamerize   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Glyburide 2nd Gen Sulfonylurea |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Human GLP-1 Incretin  Secreted by L cells located in small intestine Closes ATP-linked K+ channel Inhibits glucagon secretion & hepatic glucose secretion Stimulates insulin secretion Slows gastric emptying Promotes satiety Restores beta cell function  Promotes beta cell differentiation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Regular Human Insulin Onset 30 min-1 hr, duration 6-8 hr     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ibuprofen NSAID Propionic Acid Derivative Lacks 2nd aromatic ring ut possesss sec-butyl substituent that presumably renders drug slightly less potent |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Iloprost PGI2 analog Lowers peripheral, pulmonary, and coronary resistance Used for primary pulmonary hypertension   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inactive PGE2 ketone group eliminates activity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indomethacin NSAID Indolacetic Acid Derivative More potent than aspirin as anti-inflammatory and anti-pyretic agent One of the most potent inhibitors of COX Side effects: GI and CNS (severe frontal headache) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ketoprofen NSAID Propionic Acid Derivative Inhibitis COX and lipoxygenase |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ketorolac tromethamine NSAIDPyrrolacetic Acid Derivative
  As active as indomethacin--very potent COX inhibitor   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Latanoprost Synthetic PGF derivative Eye drop for ocular hypertension and glaucoma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Linagliptin DPP4 Inhibitor Side effects: Nasopharyngitis, hypoglycemia, pancreatitis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Liraglutide 97% homology to human GLP-1 long acting slow absorption from subcutis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lispro Insulin Rapid Acting Insulin Eliminates ability to dimerize |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | LTA4 Leukotriene (Lipoxygenase Pathway) No physiological function |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | LTB4 Leukotriene (Lipoxygenase Pathway) Increase leukocyte chemotaxis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Magnesium salicylate NSAID Type 1 salicylate ester Useful for patients with restricted sodium diet |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Meclofenamate Anthranilic Acid Analog disubstitution makes 10x more potent |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mefenamic Acid Anthranilic Acid Derivative   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Meloxicam NSAIDOxicam
 More selective as COX 2 inhibitor   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Metformin Biguanide Rarely causes hypoglycemia Can cause weight loss and decrease insulin resistance in obese patients Reported to have beneficial effects on serum lipids Side effects: Metallic taste, epigastric distress, lactic acidosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Methyl Salicylate NSAID Type 1 salicylate ester Prodrug |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Miglitol Alpha-glucosidase inhibitor   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Misoprostol Stable analog of PGE1 Used as GI protectant on long term NSAID usage Orally active prodrug Drug of choice for use with mifepristone as abortifacient   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Montelukast Leukotriene Receptor Antagonist Prophylatic and chronic use for asthma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | N-arylanthranilic Acid NSAID Anthranilic Acid Analog SAR: Monosub at 2 or disub at 2,6 to enhance activity   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Naproxen NSAID Propionic Acid Derivative Does not possess 2nd non-coplanar ring Only drug marketed in optically pure form |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nateglinide Phenylalanine Analog of sulfonylurea Stimulates insulin secretion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oxaprozin NSAIDPropionic Acid Derivative (aryl propionic acid)
 Less potent because 3 carbons between site 1 and 2  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PGD2 weak inhibitor of platelet aggregation mediates inflammation by causing vasodilation and increasing vascular permeability |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PGE1 mediates inflammation by causing vasodilaiton |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PGE2 Increases thermoregulatory set point GI Protective effect Stimulates hyperalgesia (increase sensitivity to pain) Uterine contraction Mediates inflammation by causing vasodilation and increasing vascular permeability Inhibits reabsorption of sodium and water in collecting duct |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | PGF2a Stimulate uterine muscle contraction Increase thermoregulatory set point  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PGG2 No specific physiological function |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PGH2 No specific physiological function |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PGI2 ProstaCYLCIN Inhibit platelet aggregation Potent vasodilator of smooth muscle Mediate inflammation by causing vasodilation and increasing vascular permeabilty    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Phenacetin p-aminophenol Useful for pain and fever but NOT inflammation Does not inhibit COX |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Phenformin Biguanides Removed from market due to fatal lactic acidosis Rarely causes hypoglycemia Can cause weight loss and decrease insulin resistance in obese patients Reported to have beneficial effects on serum lipids Side effects: Metallic taste, epigastric distress, lactic acidosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pioglitazone Thiazolidinedione Insulin Sensitizers Increased risk of fracture in female patients |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pramlintide Synthetic amylin analog Use in conjunction with insulin before meal |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Repaglinide Stimulates insulin secretion Related to sulfonylureas, but NOT in this class |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rofecoxib NSAID COX-2 inhibitor Discontinued due to CV side effects   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rosiglitazone Thiazolidinedione Insulin sensitizer Safety alert: increased risk of heart attack |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Salicylamide NSAID Salicylate analog Weak analgesic and antipyretic NOT anti-inflammatory Does not cause GI ulceration, absorbed only in intestine Does NOT inhibit COX |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SalsalateNSAID
 NOT irreversible, but competitive inhibitor
 Less GI irritation Transported to SI and metabolized to 2 salicylic acids  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Saxagliptin DPP4 Inhibitor Adverse effect: lymphocytopenia   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sitagliptin DPP4 Inhibitor   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sodium salicylate NSAIDType 1 salicylic acid ester
   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sodium thiosalicylate NSAID weak analgesic and anti-pyretic, also anti-inflammatory   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sulindac NSAID Indolacetic acid derivative Prodrug Only Z isomer active Fever GI disturbances because absorbed as inactive sulfoxide |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Suprofen NSAIDPropionic acid derivative
 Withdrawn due to renal toxicity Reintroduced for opthalmic use  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tolazamide 1st Gen Sulfonylurea Slow absorption, slow onset |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tolbutamide 1st Gen Sulfonylurea Rapid onset, shortest DOA Diagnostic tool for pancreatic function |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tolmetin NSAID Pyrrolacetic Acid Derivative   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Travoprost Synthetic PGF analog Available as eye drop for ocular hypertension and glaucoma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Treprostinil Sodium PGI2 analog Lowers peripheral, pulmonary, and coronary resistance Used for primary pulmonary hypertension |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | TXA2 Induce platelet aggregation, produced by plateletswhen there is tissue injury Causes vasoconstriction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | type 1 salicylic acid ester |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | type 2 salicylic acid ester |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Unoprostone isopropyl Synthetic PGF analog Available as eye drop for ocular hypertension and glaucoma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Valdecoxib NSAID COX-2 inhibitor Discontinued due to severe skin reaction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Zafirlukast Leukotriene receptor antagonist Prophylactic and chronic use to treat asthma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Zileuton 5-lipoxygenase inhibitor Indicated for prophylaxis and chronic treatment of asthma Contraindicated in patients with active liver disease or persistant hepatic function enzyme elevation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Zomepirac NSAID Pyrrolacetic Acid derivative Removed from market for anaphylactic reaction |  | 
        |  |